Aviance Capital Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-4,396
Closed -$982K – 336
2024
Q3
$982K Buy
4,396
+539
+14% +$118K 0.13% 164
2024
Q2
$785K Buy
3,857
+49
+1% +$9.97K 0.11% 168
2024
Q1
$832K Buy
3,808
+272
+8% +$59.9K 0.12% 166
2023
Q4
$804K Buy
3,536
+6
+0.2% +$1.26K 0.17% 136
2023
Q3
$710K Sell
3,530
-708
-17% -$149K 0.16% 149
2023
Q2
$879K Buy
4,238
+869
+26% +$169K 0.19% 139
2023
Q1
$664K Buy
3,369
+57
+2% +$11.7K 0.15% 155
2022
Q4
$670K Buy
+3,312
New +$647K 0.16% 156

Other funds holding LH

Aviance Capital Partners's LH Position: Q4 2024 in Review

Aviance Capital Partners sold out of Labcorp (LH) in Q4 2024, closing a stake of 4,396 shares — an estimated $982K sold.

Aviance Capital Partners first reported a position in LH in Q4 2022 and held it in 8 quarters. The position peaked at $982K in Q3 2024. 927 funds tracked by Wall St. Rank hold LH as of Q4 2024.

  • Aviance Capital Partners reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
  • Aviance Capital Partners sold 4,396 Labcorp shares in Q4 2024, an estimated $982K.
  • Aviance Capital Partners first reported a position in Labcorp in Q4 2022 and held it in 8 quarters.
  • Aviance Capital Partners's Labcorp position peaked at $982K in Q3 2024.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Aviance Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.